Evidence map›Paper›PMID 34029338›Full record

Trial reportPLoS medicine2021

SMS messaging to improve retention and viral suppression in prevention of mother-to-child HIV transmission (PMTCT) programs in Kenya: A 3-arm randomized clinical trial.

John Kinuthia, Keshet Ronen, Jennifer A Unger, Wenwen Jiang, Daniel Matemo, Trevor Perrier, Lusi Osborn, Bhavna H Chohan, Alison L Drake, Barbra A Richardson and 1 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PLoS medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02400671 (Evaluation of Mhealth Strategies to Optimize Adherence and Efficacy of PMTCT/ART), which is not on this map. Cited by 33 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02400671 nacompletednot on this map

Evaluation of Mhealth Strategies to Optimize Adherence and Efficacy of PMTCT/ART

TypeinterventionalSponsorUniversity of WashingtonRan2015 to 2020Enrolled825ConditionsmHealth, PMTCT, Adherence, Medication, SMSArmsSMS messaging
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

John KinuthiaDepartment of Research and Programs, Kenyatta National Hospital, Nairobi, Kenya.
Keshet RonenDepartment of Global Health, University of Washington, Seattle, Washington, United States of America.
Jennifer A UngerDepartment of Global Health, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0002-6317-226X
Wenwen JiangDepartment of Epidemiology, University of Washington, Seattle, Washington, United States of America.
Daniel MatemoDepartment of Research and Programs, Kenyatta National Hospital, Nairobi, Kenya.
Trevor PerrierPaul G. Allen School of Computer Science and Engineering, University of Washington, Seattle, Washington, United States of America.
Lusi OsbornDepartment of Research and Programs, Kenyatta National Hospital, Nairobi, Kenya.
Bhavna H ChohanDepartment of Global Health, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0002-2125-6799
Alison L DrakeDepartment of Global Health, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0002-4178-7706
Barbra A RichardsonDepartment of Global Health, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0001-9564-1828
Grace John-StewartDepartment of Global Health, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0002-4301-1573

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI CONNIE L CELUM · 1988 to 2026
$104.9M
WOMEN'S REPRODUCTIVE HEALTH RESEARCH CAREER DEVELOPMENTK12HD001264 · NICHD · UNIVERSITY OF WASHINGTON · PI Barbara Ann Goff · 1998 to 2026
$8.6M
Evaluation of mHealth strategies to optimize adherence and efficacy of PMTCT/ARTR01HD080460 · NICHD · UNIVERSITY OF WASHINGTON · PI JOHN-STEWART, GRACE C. · 2014 to 2018
$3.5M
Pediatric HIV-1 in Africa: Pathogenesis and ManagementK24HD054314 · NICHD · UNIVERSITY OF WASHINGTON · PI JOHN-STEWART, GRACE C. · 2006 to 2016
$1.2M
Optimizing repeat HIV testing during pregnancy and postpartum for PMTCTK01AI116298 · NIAID · UNIVERSITY OF WASHINGTON · PI DRAKE, ALISON L · 2015 to 2019
$632k
Leveraging interactive SMS messaging to monitor and support maternal mental health in KenyaK18MH122978 · NIMH · UNIVERSITY OF WASHINGTON · PI RONEN, KESHET · 2020 to 2021
$256k
NIAID NIH HHS K01 AI116298NIAID NIH HHS P30 AI027757NICHD NIH HHS K12 HD001264NICHD NIH HHS K24 HD054314NICHD NIH HHS R01 HD080460NIMH NIH HHS K18 MH122978
6 · The paper itself

Abstract

backgroundPregnant and postpartum women living with HIV (WLWH) need support for HIV and maternal child health (MCH) care, which could be provided using short message service (SMS). METHODS AND

findingsWe compared 2-way (interactive) and 1-way SMS messaging to no SMS in a 3-arm randomized trial in 6 MCH clinics in Kenya. Messages were developed using the Health Belief Model and Social Cognitive Theory; HIV messages were integrated into an existing MCH SMS platform. Intervention participants received visit reminders and prespecified weekly SMS on antiretroviral therapy (ART) adherence and MCH, tailored to their characteristics and timing. Two-way participants could message nurses as needed. Clinic attendance, viral load (VL), and infant HIV results were abstracted from program records. Primary outcomes were viral nonsuppression (VL ≥1,000 c/ml), on-time clinic attendance, loss to follow-up from clinical care, and infant HIV-free survival. Among 824 pregnant women randomized between November 2015 and May 2017, median age was 27 years, gestational age was 24.3 weeks, and time since initiation of ART was 1.0 year. During follow-up to 2 years postpartum, 9.8% of 3,150 VL assessments and 19.6% of women were ever nonsuppressed, with no significant difference in 1-way versus control (11.2% versus 9.6%, adjusted risk ratio (aRR) 1.02 [95% confidence interval (CI) 0.67 to 1.54], p = 0.94) or 2-way versus control (8.5% versus 9.6%, aRR 0.80 [95% CI 0.52 to 1.23], p = 0.31). Median ART adherence and incident ART resistance did not significantly differ by arm. Overall, 88.9% (95% CI 76.5 to 95.7) of visits were on time, with no significant differences between arms (88.2% in control versus 88.6% in 1-way and 88.8% in 2-way). Incidence of infant HIV or death was 3.01/100 person-years (py), with no significant difference between arms; risk of infant HIV infection was 0.94%. Time to postpartum contraception was significantly shorter in the 2-way arm than control. Study limitations include limited ability to detect improvement due to high viral suppression and visit attendance and imperfect synchronization of SMS reminders to clinic visits.

conclusionsIntegrated HIV/MCH messaging did not improve HIV outcomes but was associated with improved initiation of postpartum contraception. In programs where most women are virally suppressed, targeted SMS informed by VL data may improve effectiveness. Rigorous evaluation remains important to optimize mobile health (mHealth) interventions.

trial registrationClinicalTrials.gov number NCT02400671.

Indexed as

AdolescentAdultFemaleHealth CommunicationHIV InfectionsHumansInfectious Disease Transmission, VerticalKenyaMothersTelemedicineText MessagingYoung Adult

Identifiers

PMID34029338
PMCPMC8186790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.